A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Status:
Active, not recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and preliminary efficacy
of INCAGN02390 in participants with select advanced malignancies.